DrugPatentWatch Database Preview
Drugs in MeSH Category Topoisomerase II Inhibitors
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | LEVOFLOXACIN | levofloxacin | SOLUTION;ORAL | 205222-001 | May 25, 2018 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Gland Pharma Ltd | DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 209825-001 | Aug 11, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Amneal Pharms Co | DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 208888-001 | Feb 17, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| West-ward Pharms Int | DEXRAZOXANE HYDROCHLORIDE | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 076068-002 | Sep 28, 2004 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
